• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Did Huntsman’s Wider Q1 Loss and Governance Vote Just Shift Huntsman's (HUN) Investment Narrative?

    Simply Wall St·05/11/2026 06:21:22
    Listen to the news
    • Huntsman Corporation recently reported first-quarter 2026 results showing sales of US$1,420 million and a net loss of US$53 million, while shareholders voted against a proposal for an independent board chair and the company affirmed a quarterly dividend of US$0.0875 per share.
    • These developments, alongside ongoing restructuring and European plant-closure programs discussed in earlier filings, highlight the cost and governance pressures shaping Huntsman’s current operating profile.
    • We’ll now examine how Huntsman’s wider-than-expected quarterly loss and ongoing restructuring efforts may influence the company’s existing investment narrative.

    AI is about to change healthcare. These 35 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

    Huntsman Investment Narrative Recap

    To own Huntsman today, you need to be comfortable with a chemicals business that is still loss-making while trying to reshape a higher cost European footprint. The main near term catalyst remains whether restructuring can lift margins without damaging volumes, while the biggest risk is that weak end markets and European cost pressures keep earnings under water. The latest wider quarterly loss underscores this risk, but does not appear to change the core near term catalyst itself.

    The most relevant recent announcement here is Huntsman’s Q1 2026 earnings, which showed sales holding around US$1,420 million but a net loss widening to US$53 million. This keeps the spotlight firmly on whether cost cutting, plant closures and portfolio adjustments can eventually translate into cleaner earnings, or whether persistent losses will start to constrain future capital allocation options such as dividends and reinvestment.

    Yet investors should be aware that prolonged European margin pressure and restructuring costs could still...

    Read the full narrative on Huntsman (it's free!)

    Huntsman’s narrative projects $6.4 billion revenue and $43.7 million earnings by 2028.

    Uncover how Huntsman's forecasts yield a $12.69 fair value, a 14% downside to its current price.

    Exploring Other Perspectives

    HUN 1-Year Stock Price Chart
    HUN 1-Year Stock Price Chart

    Some of the most optimistic analysts were previously expecting revenue around US$6.9 billion and positive earnings by 2029, but the latest loss and ongoing European pressure could test that view, reminding you that reasonable people can read the same numbers and reach very different conclusions.

    Explore 5 other fair value estimates on Huntsman - why the stock might be worth 42% less than the current price!

    Reach Your Own Conclusion

    Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

    Searching For A Fresh Perspective?

    These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.